Pharmaceutical company, Merck is closing a Pennsylvania plant. Cherokee Pharmaceuticals, a wholly owned subsidiary of Merck Sharp & Dohme, which is a wholly owned subsidiary of Merck & Co., has filed ...

Pharmaceutical giant Merck will shut down its manufacturing site in Northumberland County, Pa., resulting in 163 job losses. Layoffs will happen in three phases with the first starting in May 2025, ...

Merck & Co Inc. has become a top contender for the most profitable value stock, but it faces some challenges. Merck boasts a forward P/E ratio of 10.36 and TTM net income of $17.117 billion. Despite ...

Merck is planning layoffs in Pennsylvania as part of a multi-year plan to wind down operations at a manufacturing plant in ...

Merck & Co. ranks among the top dividend contenders, having increased payouts for 14 consecutive years. Dividend stocks ...

Approximately 163 employees will be impacted by the pending closure of Merck’s Cherokee plant with layoffs set to begin in ...

DURHAM, N.C.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other psychedelic stocks. In contrast to drugs like cocaine or marijuana, psychedelics are ...

Investors with a lot of money to spend have taken a bullish stance on Merck & Co MRK. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

We recently published a list of 10 Best Magic Formula Stocks for 2025. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best magic formula stocks ...

Shares of Merck & Co. Inc. MRK advanced 1.34% to $90.58 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.59% to 5,861. ...

Law Offices of Howard G. Smith reminds investors of the upcoming April 14, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Merck & Co ("Merck" or ...